Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Comparative Transcriptomics Highlights New Features of the Iron Starvation Response in the Human Pathogen Candida glabrata.

Benchouaia M, Ripoche H, Sissoko M, Thiébaut A, Merhej J, Delaveau T, Fasseu L, Benaissa S, Lorieux G, Jourdren L, Le Crom S, Lelandais G, Corel E, Devaux F.

Front Microbiol. 2018 Nov 16;9:2689. doi: 10.3389/fmicb.2018.02689. eCollection 2018.

2.

JET2 Viewer: a database of predicted multiple, possibly overlapping, protein-protein interaction sites for PDB structures.

Ripoche H, Laine E, Ceres N, Carbone A.

Nucleic Acids Res. 2017 Apr 20;45(7):4278. doi: 10.1093/nar/gkw1269. No abstract available.

3.

JET2 Viewer: a database of predicted multiple, possibly overlapping, protein-protein interaction sites for PDB structures.

Ripoche H, Laine E, Ceres N, Carbone A.

Nucleic Acids Res. 2017 Jan 4;45(D1):D236-D242. doi: 10.1093/nar/gkw1053. Epub 2016 Nov 28. Erratum in: Nucleic Acids Res. 2017 Apr 20;45(7):4278.

4.

Integrated molecular portrait of non-small cell lung cancers.

Lazar V, Suo C, Orear C, van den Oord J, Balogh Z, Guegan J, Job B, Meurice G, Ripoche H, Calza S, Hasmats J, Lundeberg J, Lacroix L, Vielh P, Dufour F, Lehtiö J, Napieralski R, Eggermont A, Schmitt M, Cadranel J, Besse B, Girard P, Blackhall F, Validire P, Soria JC, Dessen P, Hansson J, Pawitan Y.

BMC Med Genomics. 2013 Dec 3;6:53. doi: 10.1186/1755-8794-6-53.

5.

Independent transcriptional reprogramming and apoptosis induction by cisplatin.

Galluzzi L, Vitale I, Senovilla L, Eisenberg T, Carmona-Gutierrez D, Vacchelli E, Robert T, Ripoche H, Jägemann N, Paccard C, Servant N, Hupé P, Lazar V, Dessen P, Barillot E, Zischka H, Madeo F, Kroemer G.

Cell Cycle. 2012 Sep 15;11(18):3472-80. doi: 10.4161/cc.21789. Epub 2012 Aug 23.

6.

Prognostic impact of vitamin B6 metabolism in lung cancer.

Galluzzi L, Vitale I, Senovilla L, Olaussen KA, Pinna G, Eisenberg T, Goubar A, Martins I, Michels J, Kratassiouk G, Carmona-Gutierrez D, Scoazec M, Vacchelli E, Schlemmer F, Kepp O, Shen S, Tailler M, Niso-Santano M, Morselli E, Criollo A, Adjemian S, Jemaà M, Chaba K, Pailleret C, Michaud M, Pietrocola F, Tajeddine N, de La Motte Rouge T, Araujo N, Morozova N, Robert T, Ripoche H, Commo F, Besse B, Validire P, Fouret P, Robin A, Dorvault N, Girard P, Gouy S, Pautier P, Jägemann N, Nickel AC, Marsili S, Paccard C, Servant N, Hupé P, Behrens C, Behnam-Motlagh P, Kohno K, Cremer I, Damotte D, Alifano M, Midttun O, Ueland PM, Lazar V, Dessen P, Zischka H, Chatelut E, Castedo M, Madeo F, Barillot E, Thomale J, Wistuba II, Sautès-Fridman C, Zitvogel L, Soria JC, Harel-Bellan A, Kroemer G.

Cell Rep. 2012 Aug 30;2(2):257-69. doi: 10.1016/j.celrep.2012.06.017. Epub 2012 Jul 26.

7.

Down-regulation of the RUNX1-target gene NR4A3 contributes to hematopoiesis deregulation in familial platelet disorder/acute myelogenous leukemia.

Bluteau D, Gilles L, Hilpert M, Antony-Debré I, James C, Debili N, Camara-Clayette V, Wagner-Ballon O, Cordette-Lagarde V, Robert T, Ripoche H, Gonin P, Swierczek S, Prchal J, Vainchenker W, Favier R, Raslova H.

Blood. 2011 Dec 8;118(24):6310-20. doi: 10.1182/blood-2010-12-325555. Epub 2011 Jul 1.

PMID:
21725049
8.

Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidy.

Bièche I, Vacher S, Lallemand F, Tozlu-Kara S, Bennani H, Beuzelin M, Driouch K, Rouleau E, Lerebours F, Ripoche H, Cizeron-Clairac G, Spyratos F, Lidereau R.

Mol Cancer. 2011 Feb 27;10:23. doi: 10.1186/1476-4598-10-23.

9.

Involvement of p38alpha in the mitotic progression of p53(-/-) tetraploid cells.

Vitale I, Jemaà M, Senovilla L, Galluzzi L, Rello-Varona S, Metivier D, Ripoche H, Lazar V, Dessen P, Castedo M, Kroemer G.

Cell Cycle. 2010 Jul 15;9(14):2823-9. Epub 2010 Jul 3.

PMID:
20686359
10.

Effects of silencing RET/PTC1 junction oncogene in human papillary thyroid carcinoma cells.

Gilbert-Sirieix M, Ripoche H, Malvy C, Massaad-Massade L.

Thyroid. 2010 Oct;20(10):1053-65. doi: 10.1089/thy.2010.0006.

PMID:
20615140
11.

miR-181a and miR-630 regulate cisplatin-induced cancer cell death.

Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, Criollo A, Servant N, Paccard C, Hupé P, Robert T, Ripoche H, Lazar V, Harel-Bellan A, Dessen P, Barillot E, Kroemer G.

Cancer Res. 2010 Mar 1;70(5):1793-803. doi: 10.1158/0008-5472.CAN-09-3112. Epub 2010 Feb 9.

12.

MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4S.

Bénard J, Raguénez G, Kauffmann A, Valent A, Ripoche H, Joulin V, Job B, Danglot G, Cantais S, Robert T, Terrier-Lacombe MJ, Chassevent A, Koscielny S, Fischer M, Berthold F, Lipinski M, Tursz T, Dessen P, Lazar V, Valteau-Couanet D.

Mol Oncol. 2008 Oct;2(3):261-71. doi: 10.1016/j.molonc.2008.07.002. Epub 2008 Jul 23.

13.

PTCH1 +/- dermal fibroblasts isolated from healthy skin of Gorlin syndrome patients exhibit features of carcinoma associated fibroblasts.

Valin A, Barnay-Verdier S, Robert T, Ripoche H, Brellier F, Chevallier-Lagente O, Avril MF, Magnaldo T.

PLoS One. 2009;4(3):e4818. doi: 10.1371/journal.pone.0004818. Epub 2009 Mar 16.

14.

Recurrent overexpression of c-IAP2 in EBV-associated nasopharyngeal carcinomas: critical role in resistance to Toll-like receptor 3-mediated apoptosis.

Friboulet L, Pioche-Durieu C, Rodriguez S, Valent A, Souquère S, Ripoche H, Khabir A, Tsao SW, Bosq J, Lo KW, Busson P.

Neoplasia. 2008 Nov;10(11):1183-94.

15.

A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib.

de La Motte Rouge T, Galluzzi L, Olaussen KA, Zermati Y, Tasdemir E, Robert T, Ripoche H, Lazar V, Dessen P, Harper F, Pierron G, Pinna G, Araujo N, Harel-Belan A, Armand JP, Wong TW, Soria JC, Kroemer G.

Cancer Res. 2007 Jul 1;67(13):6253-62.

16.

Robust interlaboratory reproducibility of a gene expression signature measurement consistent with the needs of a new generation of diagnostic tools.

Ach RA, Floore A, Curry B, Lazar V, Glas AM, Pover R, Tsalenko A, Ripoche H, Cardoso F, d'Assignies MS, Bruhn L, Van't Veer LJ.

BMC Genomics. 2007 Jun 7;8:148.

17.

Microarray-based identification of tenascin C and tenascin XB, genes possibly involved in tumorigenesis associated with neurofibromatosis type 1.

Lévy P, Ripoche H, Laurendeau I, Lazar V, Ortonne N, Parfait B, Leroy K, Wechsler J, Salmon I, Wolkenstein P, Dessen P, Vidaud M, Vidaud D, Bièche I.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):398-407. Epub 2007 Jan 3.

18.

Interrelation between polyploidization and megakaryocyte differentiation: a gene profiling approach.

Raslova H, Kauffmann A, Sekkaï D, Ripoche H, Larbret F, Robert T, Tronik Le Roux D, Kroemer G, Debili N, Dessen P, Lazar V, Vainchenker W.

Blood. 2007 Apr 15;109(8):3225-34. Epub 2006 Dec 14.

PMID:
17170127
19.

ppGalNAc-T13: a new molecular marker of bone marrow involvement in neuroblastoma.

Berois N, Blanc E, Ripoche H, Mergui X, Trajtenberg F, Cantais S, Barrois M, Dessen P, Kågedal B, Bénard J, Osinaga E, Raguénez G.

Clin Chem. 2006 Sep;52(9):1701-12. Epub 2006 Jul 27. Erratum in: Clin Chem. 2006 Dec;52(12):2315-8.

PMID:
16873292
20.

Follicular thyroid tumors with the PAX8-PPARgamma1 rearrangement display characteristic genetic alterations.

Lacroix L, Lazar V, Michiels S, Ripoche H, Dessen P, Talbot M, Caillou B, Levillain JP, Schlumberger M, Bidart JM.

Am J Pathol. 2005 Jul;167(1):223-31.

21.

Prion protein prevents human breast carcinoma cell line from tumor necrosis factor alpha-induced cell death.

Diarra-Mehrpour M, Arrabal S, Jalil A, Pinson X, Gaudin C, Piétu G, Pitaval A, Ripoche H, Eloit M, Dormont D, Chouaib S.

Cancer Res. 2004 Jan 15;64(2):719-27.

22.

Supplemental Content

Loading ...
Support Center